4//SEC Filing
STROME MARK E 4
Accession 0001213900-24-113655
CIK 0001101026other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 6:47 AM ET
Size
12.0 KB
Accession
0001213900-24-113655
Insider Transaction Report
Form 4
STROME MARK E
10% Owner
Transactions
- Purchase
Common Stock
2024-12-26$20.19/sh+75,000$1,514,250→ 398,683 total(indirect: By entity) - Purchase
Common Stock Purchase Warrant
2024-12-26+7,500→ 44,171 total(indirect: By entity)Exercise: $20.19From: 2024-12-26Exp: 2029-12-26→ Common Stock (7,500 underlying)
Transactions
- Purchase
Common Stock
2024-12-26$20.19/sh+75,000$1,514,250→ 398,683 total(indirect: By entity) - Purchase
Common Stock Purchase Warrant
2024-12-26+7,500→ 44,171 total(indirect: By entity)Exercise: $20.19From: 2024-12-26Exp: 2029-12-26→ Common Stock (7,500 underlying)
STROME GROUP, INC.
Other
Transactions
- Purchase
Common Stock Purchase Warrant
2024-12-26+7,500→ 44,171 total(indirect: By entity)Exercise: $20.19From: 2024-12-26Exp: 2029-12-26→ Common Stock (7,500 underlying) - Purchase
Common Stock
2024-12-26$20.19/sh+75,000$1,514,250→ 398,683 total(indirect: By entity)
Footnotes (1)
- [F1]The reported securities are held by Strome Mezzanine Fund II, LP ("SMF II). Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for the shares held by SME II. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), except to the extent of their pecuniary interest therein. This filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
Documents
Issuer
Zivo Bioscience, Inc.
CIK 0001101026
Entity typeother
Related Parties
1- filerCIK 0000919484
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 6:47 AM ET
- Size
- 12.0 KB